Pharmaceutical giant Novartis said Tuesday it will cut more than 2,000 jobs in Switzerland by 2022, while some 400 jobs could go in Britain as part of a global restructuring.
Other
Sep 25, 2018
0
22
Swiss pharmaceutical giant Novartis said Friday it planned to cut loose its Alcon eye care division, and aimed to buy back $5.0 billion of its own shares by the end of 2019.
Business
Jun 29, 2018
0
5
A new antibody could dramatically boost strength and muscle mass in patients with cancer, chronic obstructive pulmonary disease (COPD), sporadic inclusion body myositis, and in elderly patients with sarcopenia according to ...
Cell & Microbiology
Dec 19, 2013
0
0
Genome researchers from Bielefeld University's Center for Biotechnology (CeBiTec) headed by Professor Dr. Alfred Pühler have succeeded in sequencing the genome of the Chinese hamster. The Chinese hamster supplies the cell ...
Biotechnology
Aug 21, 2013
0
0
MIT chemical engineers have discovered that arrays of billions of nanoscale sensors have unique properties that could help pharmaceutical companies produce drugs—especially those based on antibodies—more safely and efficiently.
Bio & Medicine
Aug 16, 2013
1
0
Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market.
Business
May 20, 2013
0
0
(Phys.org) —Every available cancer drug is susceptible to resistance, according to Mansoor Amiji, Distinguished Professor and chair of the Department of Pharmaceutical Sciences. Tumors grow more quickly than blood vessels, ...
Bio & Medicine
Mar 19, 2013
1
0
(Phys.org)—Though we may not realize it, our minds spend a lot of time discarding information. More like a big-box store than a box of chocolates, life is constantly throwing us information we don't ...
Other
Jan 14, 2013
0
0
Traditional drug manufacturing is a time-consuming process. Active pharmaceutical ingredients are synthesized in a chemical manufacturing plant and then shipped to another site, where they are converted into giant batches ...
Other
Mar 12, 2012
0
0
(PhysOrg.com) -- Scientists from the Friedrich Miescher Institute for Biomedical Research (FMI) publish exciting new results on the regulation of cell fate in the scientific journal Nature. They identified novel epigenetic ...
Cell & Microbiology
Dec 15, 2011
0
0
Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland, ranking number one in revenues, which accounted over $53 billion in 2008, and number three in sales, which accounted 36.172 billon in 2008 . Novartis is one of the largest healthcare companies in the world and a leading giant among pharmaceutical companies. Novartis manufactures drugs such as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec / Glivec), cyclosporin A (Neoral / Sandimmun), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), and others. Novartis owns Sandoz, a large manufacturer of generic drugs. The company formerly owned the Gerber Products Company, a major infant and baby products producer, but sold it to Nestlé on 1 September 2007.
Novartis is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
This text uses material from Wikipedia, licensed under CC BY-SA
